Oramed Pharmaceuticals Financials
| ORMP Stock | USD 2.21 0.02 0.91% |
Oramed |
Oramed Pharmaceuticals Stock Summary
Oramed Pharmaceuticals competes with Protalix Biotherapeutics, Corvus Pharmaceuticals, Aldeyra, Checkpoint Therapeutics, and BioLineRx. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. Oramed Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.| Foreign Associate | Israel |
Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US68403P2039 |
| CUSIP | 68403P203 68403P104 |
| Location | New York; U.S.A |
| Business Address | 1185 Avenue of |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.oramed.com |
| Phone | 844 967 2633 |
| Currency | USD - US Dollar |
Oramed Pharmaceuticals Key Financial Ratios
| Return On Equity | 0.0289 | ||||
| Return On Asset | -0.0412 | ||||
| Target Price | 3.25 | ||||
| Beta | 1.77 |
Oramed Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oramed Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Oramed Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oramed Pharmaceuticals competition to find correlations between indicators driving Oramed Pharmaceuticals's intrinsic value. More Info.Oramed Pharmaceuticals is regarded third in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Oramed Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Oramed Pharmaceuticals Systematic Risk
Oramed Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Oramed Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Oramed Pharmaceuticals correlated with the market. If Beta is less than 0 Oramed Pharmaceuticals generally moves in the opposite direction as compared to the market. If Oramed Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Oramed Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Oramed Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Oramed Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Oramed Pharmaceuticals is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Oramed has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Oramed Pharmaceuticals' financials are consistent with your investment objective using the following steps:- Review Oramed Pharmaceuticals' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Oramed Pharmaceuticals' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Oramed Pharmaceuticals' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Oramed Pharmaceuticals' stock is overvalued or undervalued.
Oramed Pharmaceuticals February 7, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Oramed Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Oramed Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oramed Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Oramed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oramed Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 10.81 | |||
| Value At Risk | (3.57) | |||
| Potential Upside | 3.86 |
Additional Tools for Oramed Stock Analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.